Bumetanide acts on inflammation post-TBI
For in vivo ephys experiments performed with the NeuroNexus SmartBox Pro™ and Radiens™ Allego software, Marine Tessier et al. with Claudio Rivera’s groups at Aix Marseille University and the University of Helsinki used NeuroNexus A1x16-3mm-100-177-A16 probes. They recorded LFP and single-units of wide-spiking and narrow-spiking neurons in the hippocampus of mice subjected to controlled cortical impact (CCI) as a model of brain injury to study non-neuronal targets of bumetanide.
Related Topics
Intern Spotlight: A Transformative Journey in Neurotechnology
We are thrilled to share the incredible …
Read publication
Exploring Auditory Neuroscience at the Biennial Woods Hole Summer School: A Deep Dive into the Biology of the Inner Ear
Every two years, some of the brightest m…
Read publication
7 Years Later: Revolutionizing Neural Research with SiC
NeuroNexus is committed to continuous im…
Read publication
A brief history of electrode technology
Our history of microelectrode technology…
Read publication